Latest Capital Raises News

Golden Horse Minerals has swiftly completed its inaugural drilling campaign at Hakes Find shortly after its ASX debut, setting the stage for an active exploration year in 2025.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

Forbidden Foods Limited has more than doubled its group revenues in Q2 FY25 following the acquisition of Oat Milk Goodness, driven by expanded retail distribution and strong ecommerce growth.

Insignia Financial has received a second revised indicative proposal from Bain Capital to acquire the company at A$4.60 per share, matching a rival bid and signaling a competitive acquisition process.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.

Sierra Nevada Gold's December 2024 quarterly report reveals promising high-grade silver intersections at its Blackhawk Epithermal Project, alongside a successful capital raise and strategic board appointment.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

Iceni Gold Limited reports significant expansion of the Guyer gold anomaly at its 14 Mile Well Project, unveiling robust gold mineralisation across a broad footprint. The company prepares for a major reverse circulation drilling campaign backed by Gold Road Resources.

Icetana Limited has announced a fully underwritten renounceable entitlement offer to raise approximately $2.65 million, aiming to bolster sales, marketing, and product development efforts. The offer, priced at $0.02 per new share, opens on February 3 and closes on February 14, 2025.

Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.